20010205
 Schizophrenia Drug From Pfizer Wins FDA's Approval   By By Scott Hensley, The Wall Street Journal,  Feb 6, 2001  "We got a very competitive label which is consistent with our safety and efficacy data," said Steven Romano, senior medical director for ziprasidone. Pfizer said the medicine probably would be available to patients sometime next month. The price and brand name of the drug haven't been decided. The medication was originally expected to be marketed as Zeldox; Pfizer has proposed a new name, Geodon, as an alternative.   
